Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| CIPROFLOXACIN | 10445517 canada inc / north pharmaceuticals / dac pharmaceuticals | Marketed | Feb 26, 2025 | Marketed |
| AURO-AZILSARTAN MEDOXOMIL | auro pharma inc | Marketed | Feb 26, 2025 | Marketed |
| AZITHROMYCIN | 10445517 canada inc / north pharmaceuticals / dac pharmaceuticals | Marketed | Feb 26, 2025 | Marketed |
| OLAY GLOW + PROTECT SPF STICK | procter & gamble inc | Marketed | Feb 26, 2025 | Marketed |
| AURO-AZILSARTAN MEDOXOMIL | auro pharma inc | Marketed | Feb 26, 2025 | Marketed |
| SUNSCREEN BROAD SPECTRUM SPF 50 | mary kay cosmetics ltd | Marketed | Feb 25, 2025 | Marketed |
| HYPO-CHLOR NEUTRAL 0.52% | VELTEK ASSOCIATES INC | Marketed | Feb 22, 2025 | Marketed |
| HYPO-CHLOR NEUTRAL 0.25% | VELTEK ASSOCIATES INC | Marketed | Feb 22, 2025 | Marketed |
| APO-VILAZODONE | Apotex Inc | Marketed | Feb 21, 2025 | Marketed |
| APO-VILAZODONE | Apotex Inc | Marketed | Feb 21, 2025 | Marketed |
| JAMP KETOTIFEN OPHTHALMIC | Jamp Pharma Corporation | Marketed | Feb 21, 2025 | Marketed |
| APO-VILAZODONE | Apotex Inc | Marketed | Feb 21, 2025 | Marketed |
| C-HEX 55 | GENESIS CHEMICALS LTD | Marketed | Feb 20, 2025 | Marketed |
| GLADIATOR GOLD | GENESIS CHEMICALS LTD | Marketed | Feb 20, 2025 | Marketed |
| APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc | Marketed | Feb 18, 2025 | Marketed |
| APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc | Marketed | Feb 18, 2025 | Marketed |
| APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc | Marketed | Feb 18, 2025 | Marketed |
| APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc | Marketed | Feb 18, 2025 | Marketed |
| APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc | Marketed | Feb 18, 2025 | Marketed |
| APO-LISDEXAMFETAMINE CAPSULES | Apotex Inc | Marketed | Feb 18, 2025 | Marketed |
